Biocryst Pharmaceuticals (BCRX) EBITDA Margin (QoQ) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49,367.00 |
| Mar 31, 2026 | -3.72 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 33.00 |
| Jun 30, 2025 | 365.00 |
| Mar 31, 2025 | 1,801.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -144.00 |
| Jun 30, 2024 | 2,363.00 |
| Mar 31, 2024 | 3,007.00 |
| Dec 31, 2023 | -3,194.00 |
| Sep 30, 2023 | 1,135.00 |
| Jun 30, 2023 | 1,622.00 |
| Mar 31, 2023 | 1,691.00 |
| Dec 31, 2022 | -3,521.00 |
| Sep 30, 2022 | 2,998.00 |
| Jun 30, 2022 | 4,708.00 |
| Mar 31, 2022 | 1,057.00 |
| Dec 31, 2021 | -189.00 |
| Sep 30, 2021 | -4,954.00 |